Evorpacept (ALX148)
AT148006
Phase 3 small_molecule active
Quick answer
Evorpacept (ALX148) for Gastric Cancer is a Phase 3 program (small_molecule) at ALX ONCOLOGY HOLDINGS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALX ONCOLOGY HOLDINGS INC
- Indication
- Gastric Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active